Showing results (11-20 of 177) with videos related to
Sort By:
Pageof 18
BMJ Case Reports|August 9, 2017
An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergolineShalini Kunasegaran, Michael S Croxson, Ian Holdaway, et al.Orthopaedics & Traumatology, Surgery & Research : OTSR|October 29, 2021
Liner type has no impact on bone mineral density changes around a 3D printed trabecular titanium acetabular componentAntonio Klasan, Ali Bayan, Ian Holdaway, et al.Clinical Endocrinology|July 22, 2014
Adverse skeletal effects of drugs - beyond GlucocorticoidsSusannah O'Sullivan, Andrew GreyClinical Endocrinology|January 30, 2023
Increased workload without clinical benefit: Results following implementation of the ACR-TIRADS system for thyroid nodulesMark J Bolland, Andrew GreyExpert Opinion on Investigational Drugs|April 19, 2005
Emerging and potential therapies for osteoporosisAndrew Grey, Ian R ReidThe New Zealand Medical Journal|October 6, 2022
Is PHARMAC's decision-making fair, cost-effective and clinically effective? Observations from the real worldMark J Bolland, Andrew GreyBMJ Open|October 9, 2014
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication recordMark J Bolland, Andrew GreyPlos One|January 1, 2015
A case study of discordant overlapping meta-analyses: vitamin d supplements and fractureMark J Bolland, Andrew GreyTherapeutics and Clinical Risk Management|March 25, 2008
Differences between the bisphosphonates for the prevention and treatment of osteoporosisAndrew Grey, Ian R ReidThe Journal of Clinical Endocrinology and Metabolism|February 12, 2010
Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelinesMark J Bolland, Andrew GreyPageof 18